GB9915306D0 - New macrolide compounds,new use of known and new macrolides - Google Patents

New macrolide compounds,new use of known and new macrolides

Info

Publication number
GB9915306D0
GB9915306D0 GBGB9915306.6A GB9915306A GB9915306D0 GB 9915306 D0 GB9915306 D0 GB 9915306D0 GB 9915306 A GB9915306 A GB 9915306A GB 9915306 D0 GB9915306 D0 GB 9915306D0
Authority
GB
United Kingdom
Prior art keywords
new
macrolides
macrolide compounds
compounds
macrolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9915306.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto Biomar SA
Original Assignee
Instituto Biomar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Biomar SA filed Critical Instituto Biomar SA
Priority to GBGB9915306.6A priority Critical patent/GB9915306D0/en
Publication of GB9915306D0 publication Critical patent/GB9915306D0/en
Priority to PCT/GB2000/002511 priority patent/WO2001002413A1/en
Priority to AU55573/00A priority patent/AU5557300A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9915306.6A 1999-06-30 1999-06-30 New macrolide compounds,new use of known and new macrolides Ceased GB9915306D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9915306.6A GB9915306D0 (en) 1999-06-30 1999-06-30 New macrolide compounds,new use of known and new macrolides
PCT/GB2000/002511 WO2001002413A1 (en) 1999-06-30 2000-06-30 BAFIlOMYCIN DERIVATIVES WITH ANTICANCER ACTIVITY
AU55573/00A AU5557300A (en) 1999-06-30 2000-06-30 Bafilomycin derivatives with anticancer activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9915306.6A GB9915306D0 (en) 1999-06-30 1999-06-30 New macrolide compounds,new use of known and new macrolides

Publications (1)

Publication Number Publication Date
GB9915306D0 true GB9915306D0 (en) 1999-09-01

Family

ID=10856354

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9915306.6A Ceased GB9915306D0 (en) 1999-06-30 1999-06-30 New macrolide compounds,new use of known and new macrolides

Country Status (3)

Country Link
AU (1) AU5557300A (en)
GB (1) GB9915306D0 (en)
WO (1) WO2001002413A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4351629B2 (en) * 2002-07-02 2009-10-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Bafilomycin-like metabolites from a novel micromonospora species
US8669376B2 (en) 2004-02-17 2014-03-11 University Of South Florida Cytotoxin compounds and methods of isolation
CA2556550A1 (en) 2004-02-17 2005-09-01 University Of South Florida Cytotoxin compound and method of isolation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS625990A (en) * 1985-06-20 1987-01-12 Sumitomo Chem Co Ltd Antibiotic substance and production thereof
US5324720A (en) * 1992-03-20 1994-06-28 Merck & Co., Inc. Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
US5306716A (en) * 1992-03-20 1994-04-26 Merck & Co., Inc. Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds
JPH09301991A (en) * 1996-05-14 1997-11-25 Mercian Corp Cancer metastasis inhibitor

Also Published As

Publication number Publication date
AU5557300A (en) 2001-01-22
WO2001002413A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
PL365012A1 (en) Macrolide antibiotics
PL348333A1 (en) Macrolides
PL351312A1 (en) New compounds, their preparation and use
IL137024A0 (en) Novel macrolides
PL337606A1 (en) Derivatives of erythromycin 9-oxime
HK1048999A1 (en) Azepinoindole derivatives, their preparation and use thereof
PL341647A1 (en) Novel derivatives of erythromycin
HK1042707A1 (en) Ketolide antibiotics
HK1045523A1 (en) 13-methyl erythromycin derivatives
HK1034722A1 (en) Antipicornaviral compounds, their preparation and use
PL348098A1 (en) Novel erythromycin derivatives, preparation method and use as medicines
IL142628A0 (en) Novel macrolide antibiotics
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
IL145256A0 (en) Erythromycin derivatives
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
PL361276A1 (en) Macrolide solvates
AU5789001A (en) Macrolide antiinfective agents
HUP0104510A3 (en) Benzofuran derivatives, their preparation and use
GB9915306D0 (en) New macrolide compounds,new use of known and new macrolides
HK1045698A1 (en) Avermectin derivatives
PL353770A1 (en) Streptomyces avermitilis
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use
HK1038928A1 (en) Macrolide intermediates in the preparation of clarithromycin
PL353874A1 (en) Streptomyces avermitilis
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)